A Sober Look At This Psychedelic Stock
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
Investor
5 Stocks Under $10 With Solid Alpha Potential For Aggressive Traders
“With the number of new equity traders skyrocketing over the past year due to the Reddit/WallStreetBets popularity, locating good ideas to trade has become even…
As Small-Cap Stocks Outperform, Here Are 14 That Are Undervalued
“After lagging the broad market rebound in 2020, smaller companies staged a comeback in the latter part of that year and have been on a…
3 Small-Cap Stocks With Big Potential
“While one could argue that small cap stocks are a bit riskier than large, well-funded behemoths, they’re also the place to look for the next…
Balance Promising Growth And Interest Rate Risk With These 30 Stocks
As the economic recovery continues, Goldman Sachs is advising investors to “balance the appeal of promising businesses with the risk that [interest] rates rise further…
How To Be A Successful Trend Trader – And Supercharge Your Profit Potential This Year
When it comes to the first requirement to be a successful trend trader, the author of today’s article advises “You need to follow the ‘smart…
Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?
With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in…
5 Penny Stocks With Lots Of Hype – And Red Flags
“The allure of penny stocks lies in their potential to deliver massive gains in a short period of time. But in exchange for that opportunity,…
These Biotech Stocks Could Get “Let Out Of The Cage” This Year
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…